Research code: 0-1-1-20222
Ethics code: IR.IUMS.REC.1401.616
, Fateme.kar9675@gmail.com
Abstract: (438 Views)
Introduction
COVID-19 is a disease which affects various organs of the body and has had significant mortality and morbidity around the world. Despite numerous evaluations made on different organs, there are far less reports about the biliary system and ducts. Therefore; we conducted this study with the aim of investigating the prevalence of acalculous cholecystitis and gallbladder hydrops in COVID-19 patients in Firoozabadi hospital in 2020-2021.
Materials and methods
In this cross-sectional study we evaluated all of the COVID-19 patients that were admitted in Firoozabadi hospital during 2020-2021. The assessment of acalculous cholecystitis and gallbladder hydrops in these patients was done based on clinical and imaging records from patients' files. The assessment of the severity of COVID-19 in the patients was also done based on clinical examinations, imaging and paraclinical findings. Finally, these findings were evaluated with the use of statistical methods.
Results
Among 943 patients present in this study, 546 were men (57.9%) and 397 were women (42.1%). The mean age was 58.91±7.49 years, minimum and maximum ages were 40 and 76 years, respectively. 74 of the patients (7.8%) had multi-organ involvement and 869 patients (92.2%) had single-organ involvement. Furthermore, the most prevalent severity of COVID-19 was moderate which was present in 712 patients (75.5%). The prevalence of acalculous cholecystitis and gallbladder hydrops were 135 (14.3%) and 21 (2.2%), respectively. There was a significant difference between the prevalence of acalculous cholecystitis and gallbladder hydrops in male and female patients (p-value<0.05). There were also significant differences between the prevalence of acalculous cholecystitis and gallbladder hydrops separately sorted by organ involvement and COVID-19 severity (p-value<0.05).
Conclusion
The results of our study show the presence and the prevalence of biliary diseases such as acalculous cholecystitis and gallbladder hydrops in COVID-19 patients which should be evaluated by clinical examination and imaging techniques. Moreover, our results show that severe forms of COVID-19 and multi-organ involvement are among important parameters which determine the prognosis of acalculous cholecystitis and gallbladder hydrops patients and need further investigation to prevent the aggravation of these diseases.
COVID-19 is a disease which affects various organs of the body and has had significant mortality and morbidity around the world. Despite numerous evaluations made on different organs, there are far less reports about the biliary system and ducts. Therefore; we conducted this study with the aim of investigating the prevalence of acalculous cholecystitis and gallbladder hydrops in COVID-19 patients in Firoozabadi hospital in 2020-2021.
Materials and methods
In this cross-sectional study we evaluated all of the COVID-19 patients that were admitted in Firoozabadi hospital during 2020-2021. The assessment of acalculous cholecystitis and gallbladder hydrops in these patients was done based on clinical and imaging records from patients' files. The assessment of the severity of COVID-19 in the patients was also done based on clinical examinations, imaging and paraclinical findings. Finally, these findings were evaluated with the use of statistical methods.
Results
Among 943 patients present in this study, 546 were men (57.9%) and 397 were women (42.1%). The mean age was 58.91±7.49 years, minimum and maximum ages were 40 and 76 years, respectively. 74 of the patients (7.8%) had multi-organ involvement and 869 patients (92.2%) had single-organ involvement. Furthermore, the most prevalent severity of COVID-19 was moderate which was present in 712 patients (75.5%). The prevalence of acalculous cholecystitis and gallbladder hydrops were 135 (14.3%) and 21 (2.2%), respectively. There was a significant difference between the prevalence of acalculous cholecystitis and gallbladder hydrops in male and female patients (p-value<0.05). There were also significant differences between the prevalence of acalculous cholecystitis and gallbladder hydrops separately sorted by organ involvement and COVID-19 severity (p-value<0.05).
Conclusion
The results of our study show the presence and the prevalence of biliary diseases such as acalculous cholecystitis and gallbladder hydrops in COVID-19 patients which should be evaluated by clinical examination and imaging techniques. Moreover, our results show that severe forms of COVID-19 and multi-organ involvement are among important parameters which determine the prognosis of acalculous cholecystitis and gallbladder hydrops patients and need further investigation to prevent the aggravation of these diseases.
Type of Study: Research |
Subject:
General Surgery
Send email to the article author
